Pharmacological activities of ruscogenin: A narrative review

Abstract

Ruscogenin, a steroidal sapogenin, is primarily derived from the genus Ruscus. It demonstrates a wide range of pharmacological actions that hold substantial promise for therapeutic use. By conducting a comprehensive examination of electronic databases including PubMed, ScienceDirect, and SciFinder, we identified studies on ruscogenin to date. This review aims at emphasizing the findings related to the bioactivities of ruscogenin, particularly its protective activities in neurological and inflammatory disorders, hemorrhoids, and cancer. Ruscogenin has been demonstrated to possess anti-ulcer, anti-osteoporotic, and skin-lightening properties as a therapeutic agent. It has also been proven effective in managing metabolic disorders by reducing inflammation and improving lipid metabolism, particularly in conditions such as non-alcoholic steatohepatitis and diabetic nephropathy. Reports indicate that it can prevent acute lung injury by protecting pulmonary endothelial cells from apoptosis and modulating inflammatory cytokines. Additionally, ruscogenin promotes neurological recovery by mitigating oxidative stress. It also shows anti-cancer properties, leading to apoptosis and hindering metastasis, particularly in pancreatic and hepatocellular carcinoma. This review summarizes the potential medical applications of ruscogenin and underscores the need for further research on its mechanisms of action.

Keywords

Ruscogenin / Steroidal sapogenin / Ruscus aculeatus / Pharmacological activity

Conflict of interest statement

The authors declare that they have no conflict of interest.

Funding

The study received no extramural funding.

Authors’ contributions

MBS and PDV designed and conceptualized the review idea and were involved in data acquisition, manuscript preparation, review and approval of final version. SRR helped in analysis of data, preparation and editing of the manuscript. NJL was involved in the definition of intellectuality and literature search. KDP and AAR did a comprehensive literature search, compiled the data and prepared draft manuscript.

Publisher’s note

The Publisher of the Journal remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

[1] Vlase L, Kiss B, Balica G, Tas M, Crisan G, Leucuta S. High-throughput LC/MS/MS analysis of ruscogenin and neoruscogenin in Ruscus aculeatus L. J AOAC Int 2009; 92(4): 1055-1059.

[2] Masullo M, Pizza C, Piacente S. Ruscus genus: A rich source of bioactive steroidal saponins. Plant Med 2016; 82(18): 1513-1524.

[3] Kostova I, Dinchev D. Saponins in Tribulus terrestris—Chemistry and bioactivity. Phytochem Rev 2005; 4(2-3): 111-137.

[4] Balica G, Vostinaru O, Tamas M, Crisan G, Mogosan C. Antiinflammatory effect of the crude steroidal saponin from the rhizomes of Ruscus aculeatus L. (Ruscaceae) in two rat models of acute inflammation. J Food Agri Environ 2013; 11(3): 106-108.

[5] Naidoo CM, Gangaram S, Naidoo Y, Dewir YH. Bioactive compounds and biological activities of Ruscus species. In: Murthy HN, Paek KY, Park SY (eds.) Bioactive compounds in the storage organs of plants, reference series in phytochemistry. Cham, Switzerland: Springer Nature; 2023, p. 1-20.

[6] Nikolov S, Gusev C. Chemotaxonomic comparison of the genera Asparagus and Ruscus (Liliaceae). Bocconea 1997; 5(2): 765-769.

[7] Held G, Vagujfalvi D, Uresch F. Isolation of diosgenin from Asparagus sprengeri. Phytochem 1969; 8(2): 493-495.

[8] Davis S. Agave americana: Characteristics and potential breeding priorities. Plants 2022; 11(17): 2305.

[9] Narges V, Esmaeilifallah M, Dinani M. Isolation and identification of 6-methoxy parillin and coniferin from the bulbs of Allium affine L. Res Pharma Sci 2022; 17(6): 723-727.

[10] Di Maro A, Pacifico S, Fiorentino A, Galasso S, Gallicchio M, Guida V, et al. Raviscanina wild asparagus (Asparagus acutifolius L.): A nutritionally valuable crop with antioxidant and antiproliferative properties. Food Res Int 2013; 53(1): 180-188.

[11] Dhoran V, Gudadhe S. Effect of plant growth regulators on seed germination and seedling vigour in Asparagus sprengeri Regelin. Int Res J Biol Sci 2012; 1(7): 6-10.

[12] Adouni K, Chahdoura H, Mosba H, Santos-Buelg C, González-Paramás A, Fernandes A, et al. Revalorization of wild Asparagus stipularis Forssk. as a traditional vegetable with nutritional and functional properties. Food Fune 2018; 9(3): 1578-1586.

[13] Blunden G, Jaffer J, Jewers K, Griffin W. Steroidal sapogenins from leaves of Cordyline species. J Nat Prod 1981; 44(4): 441-447.

[14] Chen MH, Leong F, Gao SJ, Chen X, Lu JJ, Lin LG, et al. Comparison of Ophiopogon japonicus and Liriope spicata var. prolifera from different origins based on multi-component quantification and anticancer activity. Molecules 2023; 28(3). doi: 10.3390/molecules28031045.

[15] Floden A, Avent T. A novel spring-flowering Liriope (Asparagaceae) from central China. Phytoneuron 2019; 62: 1-9.

[16] Gomez D, Azorín J, Bastida J, Viladomat F, Codina C. Seasonal and spatial variations of alkaloids in Merendera montana in relation to chemical defense and phenology. J Chem Ecol 2003; 29: 1117-1126.

[17] Yaguchi T, Imanishi Y, Matsuzawa T, Hosoya K, Hitomi J, Nakayama M. Method for identifying heat-resistant fungi of the genus Neosartorya. J Food Protec 2012; 75(10): 1806-1813.

[18] Fantz PR. Names and species of Ophiopogon cultivated in the southeastern United States. Hort Technol 2009; 19(2): 385-394.

[19] Qi J, Hu ZF, Zhou YF, Hu YJ, Yu BY. Steroidal sapogenins and glycosides from the fibrous roots of Ophiopogon japonicus and Liriope spicata var. prolifera with anti-inflammatory activity. Chem Pharm Bull 2015; 63(3): 187-194.

[20] Tian Y, Gong P, Chang S, Xu J, Yu B, Qi J. Screening and identification of potential active components in Ophiopogonis radix against atherosclerosis by biospecific cell extraction. J Chromato 2019; 1133. doi: 10.1016/j.jchromb.2019.121817.

[21] Thapa CB, Paudel MR, Bhattarai HD, Pant KK, Devkota HP, Adhikari YP, et al. Bioactive secondary metabolites in Paris polyphylla Sm. and their biological activities: A review. Heliyon 2022; 8(2). doi: 10.1016/j.heliyon.2022.e08982.

[22] Yang G, Jiang D, Chen B, Huang J, Huang L, Li N. Biochemical compounds and pharmacological functions of a traditional Chinese medicinal herb Polygonati rhizoma. Med Plant Biol 2024; 3: e012. doi: 10.48130/mpb-0024-0009.

[23] Liu H, Lin S, Xiao D, Zheng X, Gu Y, Guo S. Evaluation of the wound healing potential of Resina draconis (Dracaena cochinchinensis) in animal models. Evid Based Complement Alternat Med 2013: 2013. doi: 10.1155/2013/709865.

[24] Guvenc A, Satir E, Coskun M. Determination of ruscogenin in Turkish Ruscus L. species by UPLC. Chromatographia 2007; 66: 141-145.

[25] Ghorbani S, Esmaeili H, Ebrahimi S, Palazon J, Sonboli A, Mirjalili M. Genetic structure, molecular and phytochemical analysis in Iranian populations of Ruscus hyrcanus (Asparagaceae). Indus Crops Prod 2020; 154:112716.

[26] Perez-Najera V, Gutiérrez-Uribe J, Antunes-Ricardo M, Hidalgo-Figueroa S, Del-Toro-Sánchez C, Salazar-Olivo L, et al. Smilax aristolochiifolia root extract and its compounds chlorogenic acid and astilbin inhibit the activity of α-amylase and α-glucosidase enzymes. Evid Based Complement Alternat Med 2018; 2018. doi: 10.1155/2018/6247306.

[27] Chhatre S, Nesari T, Somani G, Kanchan D, Sathaye S. Phytopharmacological overview of Tribulus terrestris. Pharmacog Rev 2014; 8(15): 45-49.

[28] Tansi S, Kokdil G, Toncer O, Yilmaz H. Variation in ruscogenin contents in Ruscus aculeatus L. growing wild in Southern Turkey. Asian J Chem 2007; 19: 3015-3022.

[29] Nikolov S, Joneidi M, Panova D. Quantitative determination of ruscogenin in Ruscus species by densitometric thin-layer chromatography. Pharmazie 1976; 31(9): 611-612.

[30] Ozge O, Ozgur T, Hasan Y, Bijen K, Erdal B. Biotransformation of ruscogenin by Cunninghamella blakesleeana NRRL 1369 and neoruscogenin by endophytic fungus Neosartorya hiratsukae. Phytochem 2018; 152: 1-9.

[31] National Center for Biotechnology Information. PubChem Compound Summary for CID 441893, Ruscogenin. [Online]Availablefrom:https://pubchem.ncbi.nlm.nih.gov/compound/Ruscogenin[Accessedon21June2025].

[32] Sun Q, Chen L, Gao M, Jiang W, Shao F, Li J, et al. Ruscogenin inhibits lipopolysaccharide-induced acute lung injury in mice: Involvement of tissue factor, inducible NO Synthase and nuclear factor (NF)-κB. Int Immunopharmacol 2012; 12(1): 88-93.

[33] Kawasaki T, Kawai T. Toll-like receptor signaling pathways. Front Immunol 2014; 5: 1-8.

[34] Wu Y, Wang Y, Gong S, Tang J, Zhang J, Li F, et al. Ruscogenin alleviates LPS-induced pulmonary endothelial cell apoptosis by suppressing TLR4 signaling. Biomed Pharmacother 2020; 125: 1-8.

[35] Huang YL, Kou JP, Liu JH, Liu N, Yu BY. Comparison of antiinflammatory activities of ruscogenin, a major steroidal sapogenin from radix Ophiopogon japonicus and its succinylated derivative, RUS-2HS. Drug Dev Res 2008; 69(4): 196-202.

[36] Cao G, Jiang N, Hu Y, Zhang Y, Wang G, Yin M, et al. Ruscogenin attenuates cerebral ischemia-induced blood-brain barrier dysfunction by suppressing TXNIP/NLRP3 inflammasome activation and the MAPK pathway. Int J Mol Sci 2016; 17(9). doi: 10.3390/ijms17091418.

[37] Guan T, Liu Q, Qian Y, Yang H, Kong J, Kou J, et al. Ruscogenin reduces cerebral ischemic injury via NF-KB-mediated inflammatory pathway in the mouse model of experimental stroke. Eur J Pharmacol 2013; 714(1-3): 303-311.

[38] He J, Wang Y, Xu L, Xu C, Zhu Y, Xu M, et al. Ruscogenin ameliorated Sjogren’s syndrome by inhibiting NLRP 3 inflammasome activation. Evid Based Complement Alternat Med 2022; 2022. doi: 10.1155/2022/6425121.

[39] Lu HJ, Tzeng TF, Liou SS, Chang CJ, Yang C, Wu MC, et al. Ruscogenin ameliorates experimental non-alcoholic steatohepatitis via suppressing lipogenesis and inflammatory pathway. Biomed Res Int 2014; 2014. doi: 10.1155/2014/652680.

[40] Hua H, Zhu Y, Song Y. Ruscogenin suppressed the hepatocellular carcinoma metastasis via PI3K/Akt/mTOR signaling pathway. Biomed Pharmacother 2018; 101: 115-122.

[41] Whittaker S, Marais R, Zhu A. The role of signaling pathways in the development and treatment of hepatocellular carcinoma. Oncogene 2010; 29: 4989-5005.

[42] Diniz P, Silva S, Vidigal P, Xavier M, Lima C, Faria L, et al. Expression of MAPK and PI3K/AKT/mTOR proteins according to the chronic liver disease etiology in hepatocellular carcinoma. J Oncol 2020; 2020. doi: 10.1155/2020/4609360.

[43] Ercan G, Ilbar T, Solmaz A, Gulcicek O, Karagulle O, Meric S, et al. Potent therapeutic effects of ruscogenin on gastric ulcer established by acetic acid. Asian J Surg 2020; 43(2): 405-416.

[44] Huang YL, Kou JP, Ma L, Song JX, Yu BY. Possible mechanism of the anti-inflammatory activity of ruscogenin: Role of intercellular adhesion molecule-1 and nuclear factor-κB. J Pharmacol Sci 2008; 108(2): 198-205.

[45] Chakuleska L, Michailova R, Shkondrov A, Manov V, Zlateva-Panayotova N, Marinov G, et al. Bone protective effects of purified extract from Ruscus aculeatus on ovariectomy-induced osteoporosis in rats. Food Chem Toxicol 2019; 132. doi: 10.1016/j.fct.2019.110668.

[46] Domazetovic V, Marcucci G, Iantomasi T, Brandi ML, Vincenzini MT. Oxidative stress in bone remodeling: Role of antioxidants. Clin Cases Miner Bone Metab 2017; 14(2): 209-216.

[47] Capra C. Pharmacology and toxicology of some components of Ruscus aculeatus. Fitoterapia 1972; 43: 99-113.

[48] Lu HJ, Tzeng TF, Liou SS, Da Lin S, Wu MC, Liu IM. Ruscogenin ameliorates diabetic nephropathy by its anti-inflammatory and anti-fibrotic effects in streptozotocin-induced diabetic rat. BMC Complement Altern Med 2014; 14. doi: 10.1186/1472-6882-14-110.

[49] Lim A, Tesch G. Inflammation in diabetic nephropathy. Mediators Inflamm 2012; 2012. doi: 10.1155/2012/146154.

[50] Chow F, Nikolic-Paterson D, Ozols E, Atkins R, Rollin B, Tesch G. Monocyte chemoattractant protein-1 promotes the development of diabetic renal injury in streptozotocin-treated mice. Kidney Int 2006; 69(1): 73-80.

[51] Chow F, Nikolic-Paterson D, Ozols E, Atkins R, Tesch G. Intercellular adhesion molecule-1 deficiency is protective against nephropathy in type 2 diabetic Db/Db mice. J Am Soc Nephrol 2005; 16(6): 1711-1722.

[52] Zhu R, Bi L, Kong H, Xie W, Hong Y, Wang H. Ruscogenin exerts beneficial effects on monocrotaline-induced pulmonary hypertension by inhibiting NF-κB expression. Int J Clin Exp Pathol 2015; 8(10): 12169-12176.

[53] Price LC, Wort SJ, Perros F, Dorfmüller P, Huertas A, Montani D, et al. Inflammation in pulmonary arterial hypertension. Chest 2012; 141(1): 210-221.

[54] Zhou B, Zhang J, Zhang Q, Permatasari F, Xu Y, Wu D, et al. Palmitic acid induces production of proinflammatory cytokines interleukin-6, interleukin-1β and tumor necrosis factor-α via a NFκB-dependent mechanism in HaCaT keratinocytes. Mediators Inflam 2013; 2013. doi: 10.1155/2013/530429.

[55] Liu Y, Dai Y, Xu H, Zhou Q, Li F, Yu B, et al. Ruscogenin alleviates intestinal bleeding and blood flow induced by dasatinib through ROCK/ MLC pathway. Res Square 2020. doi: 10.21203/rs.3.rs-96134/v1.

[56] Yavuz E, Karagulle O, Ercan G, Celik A, Yigitbas H, Bayrak B. Evaluation of prophylactic and therapeutic effects of ruscogenin on acute radiation proctitis: An experimental rat model. Ann Surg Treat Res 2018; 94(4): 174-182.

[57] Tiwari A, Singh R, Kumar S, Sunkaria A, Jain A. From plant to pathway: Molecular mechanisms of ruscogenin in preventing amyloid-beta aggregation through computational and experimental approaches. ACS Chem Neurosci 2025; 16(3): 500-512.

[58] Mondal S. Anticancer potential of biologically active diosgenin and its derivatives: An update. Curr Trad Med 2024; 10(1): 67-80.

[59] Huang Y, Kou J, Ma L, Song J, Yu B. Possible mechanism of the antiinflammatory activity of ruscogenin: Role of intercellular adhesion molecule-1 and nuclear factor-κB. J Pharmacol Sci 2008; 108(2): 198-205.

[60] Ma S, Liu Y. Role of ruscogenin extracted from radix Ophiopogon japonicus in antagonizing 5-hydroxytryptamine and dopamine receptors through computational screening. PLoS One 2024; 19(11). doi: 10.1371/journal.pone.0310960.

[61] Khojasteh A, Sanchez-Muñoz R, Moyano E, Bonfill M, Cusido R, Eibl R, et al. Biotechnological production of ruscogenins in plant cell and organ cultures of Ruscus aculeatus. Plant Physiol Biochem 2019; 141: 133-141.